Cargando…
Outstanding Response to Sorafenib in a Patient with Metastatic Gastrointestinal Stromal Tumour
Gastrointestinal stromal tumour (GIST) is the most common sarcoma and can be seen in any part of the gastrointestinal tract. The effect of tyrosine kinase inhibitors varies with mutation status in receptor tyrosine kinase KIT and in platelet-derived growth factor receptor A (PDGFRA). This case prese...
Autores principales: | Brinch, Charlotte, Dehnfeld, Marie, Hogdall, Estrid, Poulsen, Tim Svenstrup, Toxvaerd, Anders, Al-Farra, Gina, Bergenfeldt, Magnus, Krarup-Hansen, Anders |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8647052/ https://www.ncbi.nlm.nih.gov/pubmed/34949997 http://dx.doi.org/10.1159/000519747 |
Ejemplares similares
-
The Prognostic Value of Plasma Programmed Death Protein-1 (PD-1) and Programmed Death-Ligand 1 (PD-L1) in Patients with Gastrointestinal Stromal Tumor
por: Brinch, Charlotte Margareta, et al.
Publicado: (2022) -
DNA sequencing of cytopathologically inconclusive EUS-FNA from solid pancreatic lesions suspicious for malignancy confirms EUS diagnosis
por: Plougmann, Julie Isabelle, et al.
Publicado: (2019) -
Potential Targeted Therapies in Ovarian Cancer
por: Sisman, Yagmur, et al.
Publicado: (2022) -
Characterization of glycosphingolipids from gastrointestinal stromal tumours
por: Santos, Licínia, et al.
Publicado: (2020) -
miR-21 Expression in Cancer Cells may Not Predict Resistance to Adjuvant Trastuzumab in Primary Breast Cancer
por: Nielsen, Boye Schnack, et al.
Publicado: (2014)